Recent Posts

New Experimental Therapy CAR NKT-Cells Tested In Cancer Patients For The First Time

CAR T-cells are becoming somewhat of a household name, but a new phase I trial is, for the first time, using CAR 'NKT' cells, featuring genetic modification of a different immune cell, natural killer T-cells. Natural killer T-cells have long been known to be important in mediating the immune system's response to cancer, targeting both tumor cells and cells infected with viruses.

Read more: https://www.forbes.com/sites/victoriaforster/2019/05/01/new-experimental-therapy-car-nkt-cells-tested-in-cancer-patients-for-the-first-time/#438dc3d51aa6